Mayo Clinic and Alexandria Venture Investments contributed to a $55m extension that boosted the molecular drug developer's overall funding to $143m.

A range of new and existing backers have added $45m to ViaCyte’s series D round, which now stands at more than $115m.

Transcarent has raised $58m from Bayer and Merck, while Nvidia has bought DeepMap, one of its portfolio companies also backed by Bosch.

Ontario Teachers Pension Plan has led the round that valued the ETS-backed student recruitment platform at more than $3bn.

SoftBank Vision Fund 2 and Capital One Ventures have featured in a series E round for online recruitment and retention platform developer Eightfold AI.

The Alibaba and Groupe Artémis-backed upmarket goods marketplace issued 5.75 million shares priced at $20 each.

The immuno-oncology therapy developer has amassed at least $190m of overall funding since emerging out of Stanford University.

The immuno-oncology therapy developer has amassed at least $190m of overall funding following a series B round backed by Lilly Asia Ventures.

MassMutual has helped commercial insurance platform operator Embroker achieve $140m of total funding by backing its series C round.

A total of 40 property owners, operators and developers have helped the real estate-focused venture firm close its sophomore vehicle.